Historical shareholding details of Strategic Advisers U.S. Total Stock holdings in Travere Therapeutics Inc (TVTX)

Monthly changes of Strategic Advisers U.S. Total Stock shareholding in Travere Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Strategic Advisers U.S. Total Stock 23,294 0.03%
Jan 31, 2025 Strategic Advisers U.S. Total Stock 10,649 0.01%
Dec 31, 2024 Strategic Advisers U.S. Total Stock 10,749 0.01%
Nov 30, 2024 Strategic Advisers U.S. Total Stock 11,787 0.01%
Oct 31, 2024 Strategic Advisers U.S. Total Stock 11,166 0.01%
Sep 30, 2024 Strategic Advisers U.S. Total Stock 11,066 0.01%
Jul 31, 2024 Strategic Advisers U.S. Total Stock 13,200 0.02%
Jun 30, 2024 Strategic Advisers Large Cap 14,100 0.02%
May 31, 2024 Strategic Advisers Large Cap 15,000 0.02%
Apr 30, 2024 Strategic Advisers Large Cap 19,100 0.03%
Mar 31, 2024 Strategic Advisers Large Cap 19,100 0.03%
Feb 29, 2024 Strategic Advisers Large Cap 14,900 0.02%
Jan 31, 2024 Strategic Advisers Large Cap 11,748 0.02%
Dec 31, 2023 Strategic Advisers Large Cap 12,700 0.02%
Oct 31, 2023 Strategic Advisers® Large Cap 17,200 0.02%
Sep 30, 2023 Strategic Advisers® Large Cap 16,700 0.02%
Jul 31, 2023 Strategic Advisers® Large Cap 26,800 0.04%
Jun 30, 2023 Strategic Advisers® Large Cap 28,399 0.04%
Apr 30, 2023 Strategic Advisers® Large Cap 13,600 0.02%

View all ownership details of Travere Therapeutics Inc